Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells.

Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells. Oncotarget. 2014 Jun 30; 5(12):4129-43.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.